Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Top 12 Blue Chip Stocks to Buy At 52-Week Lows

In this article, we will look at the Top 12 Blue Chip Stocks to Buy At 52-Week Lows.

On September 30, Elyse Ausenbaugh, Head of Investment Strategy at JPMorgan Wealth Management, joined CNBC for an interview to discuss the current market rally. She noted that there is a strong momentum going forward in 2025, which is likely to continue in 2026 as well. She sees improvements in the macroeconomic environment and anticipates powerful tailwinds from significant investments in AI.

She highlighted that the current rally is driven by various factors, including the Federal Reserve cutting cycle, corporate profit margins, and infrastructural investments fueling earnings growth. In addition to this, the easing of the tariff uncertainty also acts as a positive factor for the market.

While talking about the labor market, Ausenbaugh noted that the market is bending, not breaking. She highlighted that the hiring has been slow; however, layoffs are not expected to rise anymore. While elaborating, she noted that this is because the corporate profits have been strong and companies are unlikely to lay off unless the profit weakens greatly. Ausenbaugh believes that the upside potential suggests it is a good time to stay invested in the market.

With that, let’s take a look at the Top 12 Blue Chip Stocks to Buy At 52-Week Lows.

Our Methodology

To curate the list of Top 12 Blue Chip Stocks to Buy At 52-Week Lows, we sifted through reputable financial media to get a list of Blue Chip stocks trading between 0% to 10% of their 52-week lows. Next, we cross-checked the stock price and 52-week lows from Yahoo Finance and ranked the stocks in ascending order of the number of hedge fund holders sourced from Insider Monkey’s Q2 2025 database. Please note that the data was recorded on September 29, 2025.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

Top 12 Blue Chip Stocks to Buy At 52-Week Lows

12. Unilever PLC (NYSE:UL)

Price: $59.17

52-Week Range: $54.32 – $65.66

Number of Hedge Fund Holders: 27

Unilever PLC (NYSE:UL) is one of the Top Blue Chip Stocks to Buy At 52-Week Lows. On September 30, David Hayes from Jefferies maintained a Sell rating on Unilever PLC (NYSE:UL) and reduced the price target from 3,900p to 3,800.00p.

The analyst noted that his main concern is the company’s struggles in emerging markets, such as Latin America. The tough market conditions and pricing pressures in these markets are limiting growth. He highlighted that as a result, the expected growth in this region is much lower than what the analysts forecast.

Moreover, Unilever PLC (NYSE:UL) is also facing difficulty in other key markets, including India and China. He noted that these issues weigh down the company’s overall growth prospects. On the positive side, the company is performing moderately well in developed markets, with growth slightly better than expected.

Unilever PLC (NYSE:UL) is a UK-based fast-moving consumer goods company that sells products in five main areas, including Beauty & Wellbeing, Personal Care, Home Care, Foods, and Ice Cream.

11. Amgen Inc. (NASDAQ:AMGN)

Price: $273.97

52-Week Range: $253.30 – $335.88

Number of Hedge Fund Holders: 62

Amgen Inc. (NASDAQ:AMGN) is one of the Top Blue Chip Stocks to Buy At 52-Week Lows. On September 26, Reuters reported that global drugmakers are rushing to increase their manufacturing capacity in the United States as the Trump administration is imposing hefty tariffs on pharmaceutical imports.

As a result, Amgen Inc. (NASDAQ:AMGN) is also ramping up investment to enhance its manufacturing capacity in the United States. The company earlier in August announced a $900 million investment to expand its Ohio manufacturing facility, taking its total investment in the state to $1.4 billion. More recently, in September, Amgen Inc. (NASDAQ:AMGN) announced its plan to invest more than $600 million to build a new research and development center in California. It is also investing another $650 million to expand drug manufacturing in Puerto Rico.

Amgen Inc. (NASDAQ:AMGN) is a biotechnology company that discovers and develops medicines for serious diseases.

10. Accenture plc (NYSE:ACN)

Price: $247.00

52-Week Range: $229.40 – $398.35

Number of Hedge Fund Holders: 65

Accenture plc (NYSE:ACN) is one of the Top Blue Chip Stocks to Buy At 52-Week Lows. On September 30, Accenture plc (NYSE:ACN) announced the acquisition of Aidemy Inc. after completing a successful tender offer. Aidemy is a Tokyo-based company specializing in AI and digital transformation services.

Management noted that this strategic move will strengthen the company’s LearnVantage platform, which focuses on learning and reskilling employees in key areas like generative AI. Moreover, it will also allow the company to offer full support to clients in AI-driven business reinvention, from talent development to managing AI systems.

During the tender offer from August 15 to September 29, 2025, Accenture plc (NYSE:ACN) secured enough shares to finalize the acquisition. Aidemy will become a subsidiary, and its shares will be delisted from the Tokyo Stock Exchange after all remaining shares are acquired.

Accenture plc (NYSE:ACN) is a global professional services company offering consulting, technology, and operational solutions.

9. PepsiCo, Inc. (NASDAQ:PEP)

Price: $140.17

52-Week Range: $127.60 – $177.50

Number of Hedge Fund Holders: 68

PepsiCo, Inc. (NASDAQ:PEP) is one of the Top 12 Blue Chip Stocks to Buy At 52-Week Lows. On September 25, Peter Grom from UBS maintained a Buy rating on the stock with an associated price target of $170.

The analyst has based his bullish sentiment on the long-term growth prospects of the company. However, Grom acknowledged some near-term challenges facing the company, including weak trends in the US market and softness in important international regions expected in Q3. However, the analyst noted that these challenges are well known to investors already.

Moreover, he expects attention to shift toward PepsiCo, Inc. (NASDAQ:PEP)’s potential to revive growth in its North American segment soon. Looking past the short-term issues, Grom highlights a favorable outlook for the company compared to its multinational peers. He anticipates the company can deliver organic growth in line with or better than many of them.

PepsiCo, Inc. (NASDAQ:PEP) is an international food and beverage company.

8. McDonald’s Corporation (NYSE:MCD)

Price: $302.99

52-Week Range: $276.53 – $326.32

Number of Hedge Fund Holders: 78

McDonald’s Corporation (NYSE:MCD) is one of the Top Blue Chip Stocks to Buy At 52-Week Lows. On September 17, Jon Tower from Citi maintained a Buy rating on McDonald’s Corporation (NYSE:MCD) while raising the price target from $373 to $381.

The analyst noted that the company is benefiting from its strong value-based promotions, which are attracting more customers in the short term. He also noted that there is an easier year-over-year comparison, which means that the company’s current results look stronger than last year. Lastly, Tower also sees the company’s stock to be at a higher price-to-earnings multiple in the future, thereby making it an attractive investment opportunity.

McDonald’s Corporation (NYSE:MCD) is a global foodservice retailer operating and franchising restaurants worldwide.

7. The Coca-Cola Company (NYSE:KO)

Price: $66.04

52-Week Range: $60.62 – $74.38

Number of Hedge Fund Holders: 84

The Coca-Cola Company (NYSE:KO) is one of the Top Blue Chip Stocks to Buy At 52-Week Lows. On September 29, The Coca-Cola Company (NYSE:KO) announced that it will announce its fiscal third quarter results on October 21.

The company topped Wall Street estimates during its fiscal second quarter of 2025. It delivered $12.62 billion in revenue, up 2.47% year-over-year and ahead of the consensus by $41.91 million. The EPS of $0.87 also topped estimates by $0.03. Management expects the full-year revenue to grow by 5% to 6%, with some headwinds expected in the fiscal third quarter.

However, Wall Street is bullish on the stock. On September 22, J.P. Morgan reiterated a Buy rating on The Coca-Cola Company (NYSE:KO) with a price target of $79. More recently, on September 25, Dara Mohsenian from Morgan Stanley also reiterated a Buy rating on the stock with a price target of $81.

The Coca-Cola Company (NYSE:KO) is a global beverage company offering a wide range of drinks.

6. The Procter & Gamble Company (NYSE:PG)

Price: $153.53

52-Week Range: $149.91 – $180.43

Number of Hedge Fund Holders: 88

The Procter & Gamble Company (NYSE:PG) is one of the Top Blue Chip Stocks to Buy At 52-Week Lows. On September 26, The Procter & Gamble Company (NYSE:PG) announced that it will release results for its fiscal first quarter of 2026 on October 24.

The company delivered a revenue of $20.89 billion during its fiscal fourth quarter of 2024. The revenue grew 1.74% year-over-year and came in ahead of the consensus by $46.86 million. The EPS of $1.48 also topped estimates by $0.06. Management noted that it expects the 2026 full-year revenue to grow between 1% to 5%.

Wall Street is bullish on The Procter & Gamble Company (NYSE:PG). On September 16, Filippo Falorni from Citi reiterated a Buy rating on the stock with a price target of $181. More recently, on September 25, Christopher Carey from Wells Fargo also reiterated a Buy rating on the stock while reducing the price target from $173 to $170.

The Procter & Gamble Company (NYSE:PG) produces and sells branded consumer packaged goods globally. Its products cover Beauty, Grooming, Health Care, Fabric & Home Care, and Baby & Family Care.

5. Costco Wholesale Corporation (NASDAQ:COST)

Price: $916.87

52-Week Range: $867.16 – $1,078.23

Number of Hedge Fund Holders: 91

Costco Wholesale Corporation (NASDAQ:COST) is one of the Top Blue Chip Stocks to Buy At 52-Week Lows. On September 25, Costco Wholesale Corporation (NASDAQ:COST) released its fiscal fourth quarter results for 2025.

The company delivered $86.16 billion in revenue, up 8.10% year-over-year and ahead of expectations by $99.41 million. The EPS of $5.87 also topped estimates by $0.07. Wall Street has a mixed opinion on the stock despite the outperformance.

On September 29, Steven Zaccone from Citi reiterated a Hold rating on Costco Wholesale Corporation (NASDAQ:COST) while reducing the price target from $1,065 to $990. However, on the same day, Argus Research raised the price target on the stock from $1,170 to $1,200, while reiterating a Buy rating.

Costco Wholesale Corporation (NASDAQ:COST) operates membership warehouses and e-commerce sites offering a wide range of branded and private-label products.

4. Merck & Co., Inc. (NYSE:MRK)

Price: $78.58

52-Week Range: $73.31 – $114.79

Number of Hedge Fund Holders: 92

Merck & Co., Inc. (NYSE:MRK) is one of the Top Blue Chip Stocks to Buy At 52-Week Lows. On September 30, Merck & Co., Inc. (NYSE:MRK) announced  positive results from its Phase 3 HYPERION trial of WINREVAIR in adults recently diagnosed with pulmonary arterial hypertension.

The trial included patients classified as functional class 2 or 3 and at intermediate or high risk of disease progression. Management noted that the drug reduced the risk of clinical worsening events by 76% compared to placebo. Moreover, the benefit of WINREVAIR was seen early, within six weeks of starting treatment, and sustained throughout the trial. The results were consistent across patient subgroups, including those with idiopathic PAH and connective tissue disease. Lastly, the safety profile remained consistent with previous trials.

Merck & Co., Inc. (NYSE:MRK) is a global healthcare company focused on developing and delivering prescription medicines, vaccines, and animal health products.

3. Adobe Inc. (NASDAQ:ADBE)

Price: $359.42

52-Week Range: $330.04 – $557.90

Number of Hedge Fund Holders: 104

Adobe Inc. (NASDAQ:ADBE) is one of the Top Blue Chip Stocks to Buy At 52-Week Lows. On September 30, Adobe Inc. (NASDAQ:ADBE) announced the Adobe Premiere mobile app for iPhone.

The app brings professional-level video editing to mobile devices in an easy and intuitive way. It aims to help creators edit videos quickly without complicated tools. Management noted that the app features a fast multi-track timeline for precise editing. Moreover, users can also produce studio-quality audio, including clear voiceovers and AI-powered sound effects timed perfectly.

The app allows users to edit on their phones and also send projects to their desktops for more detailed work, thereby making the process of editing seamless.

Adobe Inc. (NASDAQ:ADBE) is a global technology company that provides software and services for creating, managing, and delivering digital content.

2. Danaher Corporation (NYSE:DHR)

Price: $186.06

52-Week Range: $171.00 – $279.41

Number of Hedge Fund Holders: 115

Danaher Corporation (NYSE:DHR) is one of the Top Blue Chip Stocks to Buy At 52-Week Lows. On September 23, Danaher Corporation (NYSE:DHR) announced that it will release its fiscal third-quarter results on October 21, 2025.

The company topped Wall Street estimates during its fiscal second quarter of 2025. It delivered a revenue of $5.94 billion, up 3.36% year-over-year and ahead of expectations by $100.95 million. Moreover, the EPS of $1.80 also topped estimates by $0.16. Management expects the third quarter revenue to grow by low single digits year-over-year.

Wall Street is bullish on the stock. On September 2, RBC Capital reiterated a Buy rating on Danaher Corporation (NYSE:DHR) while reducing the price target from $250 to $241. More recently, on September 22, Bank of America Securities also reiterated a Buy rating on the stock and reduced the price target from $230 to $220.

Danaher Corporation (NYSE:DHR) is a global innovator in life sciences and diagnostics. It operates in three segments: Biotechnology, Life Sciences, and Diagnostics.

1. Salesforce, Inc. (NYSE:CRM)

Price: $245.10

52-Week Range: $226.48 – $369.00

Number of Hedge Fund Holders: 121

Salesforce, Inc. (NYSE:CRM) is one of the Top Blue Chip Stocks to Buy At 52-Week Lows. On September 25, Salesforce, Inc. (NYSE:CRM) announced the launch of MuleSoft Agent Fabric to solve the problem of AI fragmentation.

Management noted that as companies rapidly adopt AI, it has resulted in agent sprawl, which creates disconnected workflows, duplicate automations, and security gaps. This leads to chaos instead of productivity. MuleSoft Agent Fabric acts like an air traffic controller, connecting and coordinating AI agents across an enterprise into one secure, intelligent network.

Management also highlighted that AI agent adoption is expected to 327% in two years; however, most of the agents currently work in silos. MuleSoft Agent Fabric provides a foundation for governance, orchestration, and monitoring of AI agents across ecosystems.

Salesforce, Inc. (NYSE:CRM) provides customer relationship management technology to help businesses manage customer data and interactions.

While we acknowledge the potential of CRM to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CRM and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.